171 related articles for article (PubMed ID: 17654737)
1. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
Black JA; Liu S; Carrithers M; Carrithers LM; Waxman SG
Ann Neurol; 2007 Jul; 62(1):21-33. PubMed ID: 17654737
[TBL] [Abstract][Full Text] [Related]
2. Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
Black JA; Waxman SG
J Neurol Sci; 2008 Nov; 274(1-2):57-63. PubMed ID: 18485368
[TBL] [Abstract][Full Text] [Related]
3. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
[TBL] [Abstract][Full Text] [Related]
4. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
5. Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Liu S; Zwinger P; Black JA; Waxman SG
J Neurol Sci; 2014 Jun; 341(1-2):8-12. PubMed ID: 24690348
[TBL] [Abstract][Full Text] [Related]
6. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Lo AC; Saab CY; Black JA; Waxman SG
J Neurophysiol; 2003 Nov; 90(5):3566-71. PubMed ID: 12904334
[TBL] [Abstract][Full Text] [Related]
7. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
8. Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis.
Stevens M; Timmermans S; Bottelbergs A; Hendriks JJ; BrĂ´ne B; Baes M; Tytgat J
J Neuroimmunol; 2013 Aug; 261(1-2):21-8. PubMed ID: 23735284
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
Irony-Tur-Sinai M; Grigoriadis N; Lourbopoulos A; Pinto-Maaravi F; Abramsky O; Brenner T
Exp Neurol; 2006 Mar; 198(1):136-44. PubMed ID: 16423348
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
Lo AC; Black JA; Waxman SG
Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
[TBL] [Abstract][Full Text] [Related]
11. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
12. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
13. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
[TBL] [Abstract][Full Text] [Related]
14. Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis.
Reiman R; Campos Torres A; Martin BK; Ting JP; Campbell IL; Barnum SR
Neurosci Lett; 2005 Dec; 390(3):134-8. PubMed ID: 16154690
[TBL] [Abstract][Full Text] [Related]
15. Phenytoin at optimum doses ameliorates experimental autoimmune encephalomyelitis via modulation of immunoregulatory cells.
Hashiba N; Nagayama S; Araya SI; Inada H; Sonobe Y; Suzumura A; Matsui M
J Neuroimmunol; 2011 Apr; 233(1-2):112-9. PubMed ID: 21237519
[TBL] [Abstract][Full Text] [Related]
16. Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination.
Craner MJ; Lo AC; Black JA; Waxman SG
Brain; 2003 Jul; 126(Pt 7):1552-61. PubMed ID: 12805113
[TBL] [Abstract][Full Text] [Related]
17. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
Allameh A; Maleklou N; Zargari M; Sanati MH
Neurosci Lett; 2008 Jul; 439(1):111-5. PubMed ID: 18501514
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q
J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144
[TBL] [Abstract][Full Text] [Related]
19. Upregulation and colocalization of p75 and Nav1.8 in Purkinje neurons in experimental autoimmune encephalomyelitis.
Damarjian TG; Craner MJ; Black JA; Waxman SG
Neurosci Lett; 2004 Oct; 369(3):186-90. PubMed ID: 15464262
[TBL] [Abstract][Full Text] [Related]
20. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]